Ryaltris Nasal Spray 600 µg. 25 µg NASAL SPRAY
PDF Leaflet Revision Date: 25 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of allergic rhinitis and rhinoconjunctivitis in patients 6 years and older.
Dosage (summary)
Adults: 2 sprays in each nostril twice daily; Children (6-11 years): 1 spray in each nostril twice daily.
Special Populations
- Paediatric patients under 6 years
- Elderly patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Coadministration with ketoconazole may increase mometasone levels.
Contraindications
- Hypersensitivity to components
- Active or quiescent tuberculosis
- Untreated infections
- Live vaccines
Common side effects
- Dizziness
- Somnolence
- Nasal discomfort
- Epistaxis
Counselling Points
- Shake well before use
- Avoid contact with eyes
- Do not use after 30 days of opening
- Monitor for signs of infection
Serious warnings
- Hypersensitivity reactions
- Immunosuppression
- Potential for glaucoma and cataracts
- Growth suppression in children
Important Disclaimer
The Ryaltris Nasal Spray 600 µg. 25 µg NASAL SPRAY professional information leaflet below is the property of Glenmark Pharmaceuticals South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
